Your browser doesn't support javascript.
loading
The case for dosing dabigatran: how tailoring dose to patient renal function, weight and age could improve the benefit-risk ratio.
Safouris, Apostolos; Triantafyllou, Nikos; Parissis, John; Tsivgoulis, Georgios.
Affiliation
  • Safouris A; Stroke Unit, Department of Neurology, Brugmann University Hospital, Place Van Gehuchten 4, 1020 Bruxelles, Belgium.
  • Triantafyllou N; First Department of Neurology, University of Athens, School of Medicine, 'Eginition' University Hospital, Athens, Greece.
  • Parissis J; Second Department of Cardiology, University of Athens, School of Medicine, 'Attikon' University Hospital, Athens, Greece.
  • Tsivgoulis G; Second Department of Neurology, University of Athens, School of Medicine, 'Attikon' University Hospital, Athens, Greece International Clinical Research Center, St. Anne's University Hospital in Brno, Czech Republic.
Ther Adv Neurol Disord ; 8(6): 245-54, 2015 Nov.
Article in En | MEDLINE | ID: mdl-26600870
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Etiology_studies / Risk_factors_studies Language: En Journal: Ther Adv Neurol Disord Year: 2015 Document type: Article Affiliation country: Belgium Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Etiology_studies / Risk_factors_studies Language: En Journal: Ther Adv Neurol Disord Year: 2015 Document type: Article Affiliation country: Belgium Country of publication: United kingdom